Skip to main content
SpringerLink
Log in

Topiramate heads off to work for migraine

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Page MJ, Paramore LC, Rupnow M, Doshi D.Screening for migraine in an employer setting. Neurology 68 (Suppl. 1): 265-266, No. 12, 20 Mar 2007

  2. Paramore LC, Page MJ, Rupnow M, Doshi D.Burden of migraine in the employer setting. Neurology 68 (Suppl. 1): 368, No. 12, 20 Mar 2007

  3. Lofland J, Gagne J, Crivera C, Rupnow M, Pizzi L.Impact of topiramate for migraine prevention on workplace productivity: pooled results from three randomized, double-blind, placebo-controlled, multicenter trials. Neurology 68 (Suppl. 1): 265 (plus poster) abstr. P06.041, No. 12, 20 Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topiramate heads off to work for migraine. Pharmacoecon. Outcomes News 529, 3 (2007). https://doi.org/10.2165/00151234-200705290-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00005

Keywords

Search

Navigation